Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Drug based on maghemite for simultaneous reduction of gastrointestinal sodium resorption and phosphate resorption

Drug based on maghemite for simultaneous reduction of gastrointestinal sodium resorption and phosphate resorption

US Patent 10632149 · Granted Apr 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Iron(III) complexes having new contrast agent properties, for magnetic resonance2025
Method for preparing an Fe-tCDTA contrast agent and product obtainable by the me2023
Method for preparing an Fe-tCDTA contrast agent and product obtainable by the me2023
Gene signatures for cancer prognosis2021
Gene signatures for cancer prognosis2020
Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magne2020
Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magne2020
Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magne2020
Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magne2020
Cancer Biomarkers2019
Cancer biomarkers2019
Cancer biomarkers2018